Viewing Study NCT05683834

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:27 AM
Ignite Modification Date: 2026-06-25 @ 1:33 AM
Study NCT ID: NCT05683834
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-21
First Post: 2023-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epstein-Barr Virus Infection View
None Infectious Mononucleosis View
None Herpesvirus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Infectious Mononucleosis View
None Neutralizing Antibody View
None Immune Response View
None Herpesvirus View